- Home
- RANI vs PRT Comparison
RANI vs PRT Comparison
Compare RANI & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANI
- PRT
- Stock Information
- Founded
- RANI 2012
- PRT 2017
- Country
- RANI United States
- PRT United States
- Employees
- RANI 140
- PRT N/A
- Industry
- RANI Medicinal Chemicals and Botanical Products
- PRT Oil & Gas Production
- Sector
- RANI Health Care
- PRT Energy
- Exchange
- RANI Nasdaq
- PRT Nasdaq
- Market Cap
- RANI 55.3M
- PRT 52.2M
- IPO Year
- RANI 2021
- PRT N/A
- Fundamental
- Price
- RANI $1.66
- PRT $4.37
- Analyst Decision
- RANI Strong Buy
- PRT
- Analyst Count
- RANI 6
- PRT 0
- Target Price
- RANI $11.33
- PRT N/A
- AVG Volume (30 Days)
- RANI 2.3M
- PRT 58.2K
- Earning Date
- RANI 03-19-2025
- PRT 03-31-2025
- Dividend Yield
- RANI N/A
- PRT 9.99%
- EPS Growth
- RANI N/A
- PRT N/A
- EPS
- RANI N/A
- PRT 0.42
- Revenue
- RANI N/A
- PRT $6,059,380.00
- Revenue This Year
- RANI N/A
- PRT N/A
- Revenue Next Year
- RANI N/A
- PRT N/A
- P/E Ratio
- RANI N/A
- PRT $10.24
- Revenue Growth
- RANI N/A
- PRT N/A
- 52 Week Low
- RANI $1.24
- PRT $3.26
- 52 Week High
- RANI $8.75
- PRT $4.64
- Technical
- Relative Strength Index (RSI)
- RANI 54.80
- PRT 61.17
- Support Level
- RANI $1.59
- PRT $4.21
- Resistance Level
- RANI $1.90
- PRT $4.37
- Average True Range (ATR)
- RANI 0.15
- PRT 0.15
- MACD
- RANI 0.03
- PRT -0.01
- Stochastic Oscillator
- RANI 56.36
- PRT 80.26
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.
About PRT PermRock Royalty Trust Trust Units
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive 80% of the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.